Belly fat be gone? new injection heads to phase 3 trial

NCT ID NCT07526974

First seen Apr 24, 2026 · Last updated Apr 30, 2026 · Updated 2 times

Summary

This study tests an injection called CBL-514 to see if it can safely reduce belly fat. About 320 adults with moderate to severe abdominal fat will receive either the drug or a placebo. The goal is to measure fat reduction using MRI and patient reports.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUBCUTANEOUS FAT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Investigational Site 1

    Encinitas, California, 92024, United States

  • Investigational Site 10

    Arlington, Virginia, 22209, United States

  • Investigational Site 11

    Seattle, Washington, 98109, United States

  • Investigational Site 13

    Vancouver, British Columbia, V5Z 1H2, Canada

  • Investigational Site 14

    Woodbridge, Ontario, L4L 8E2, Canada

  • Investigational Site 3

    Alpharetta, Georgia, 30005, United States

  • Investigational Site 4

    Hunt Valley, Maryland, 21030, United States

  • Investigational Site 7

    Canal Winchester, Ohio, 43110, United States

  • Investigational site 12

    Melbourne, Victoria, 3141, Australia

  • Investigational site 2

    Aventura, Florida, 33180, United States

  • Investigational site 5

    Omaha, Nebraska, 68144, United States

  • Investigational site 6

    New York, New York, 10028, United States

  • Investigational site 8

    Nashville, Tennessee, 37215, United States

  • Investigational site 9

    Austin, Texas, 78759, United States

Conditions

Explore the condition pages connected to this study.